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Résumé en
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BACKGROUND: Long-term anti-cytomegalovirus (CMV) treatments in
immunocompromised patients are hampered by resistance to antiviral drugs.
Longitudinal changes in the resistance genotype may depend on changes in selective
pressure and the complexity of CMV isolates.
OBJECTIVE: To evaluate longitudinal changes in the CMV resistance genotype and
phenotype along with strain-specific variability in a patient with non-Hodgkin's
lymphoma in whom successive anti-CMV treatments failed.
STUDY DESIGN: The resistance phenotype and genotype of seven CMV isolates
collected from one patient during a 2-year follow-up period were retrospectively
analysed. In parallel, we used glycoprotein B (gB) genotyping, and a- and UL10-13-
sequence analysis to study CMV interstrain variability.
RESULTS: The patient was infected by at least three CMV strains plus variants of the
parental strains. Resistance to ganciclovir, cidofovir and foscarnet was successively
detected during the follow-up period. UL97 protein kinase changes responsible for
resistance to ganciclovir were initially detected at residues 591 and 592, and then at
position 594. Decreased sensitivity to foscarnet coincided with the appearance of
amino acid substitution N495K in DNA polymerase, whereas cross-resistance to
ganciclovir and cidofovir was due to the L501I substitution.
CONCLUSIONS: The CMV isolates obtained from our patient were complex mixtures
of strains. Changes in resistance genotypes depended on resistance selective pressure
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